Rectify Pharma Alternatives & Competitors

12 companies similar to Rectify Pharma — Developing Positive Functional Modulators (PFMs) to restore and enhance membrane...

Mineralys Therapeutics, Inc.

Public, clinical-stage biopharmaceutical company committed to developing best-in-class, no...

128 IPO $1.40B

United States

Biopharma Biotechnology +1

MBX Biosciences, Inc.

Advancing potential breakthrough medicines for endocrine diseases of substantial medical n...

87 IPO $562.50M

Carmel, United States

Kallyope

64 Grant $487.20M

New York, United States

Biotechnology Health Care +1

Primus Remedies Pvt Ltd

Enriching Lives: Delivering High-Quality, Effective Products for Diabetes and Metabolic Di...

143

Hyderabad, India

Health Care Manufacturing +1

Track all Rectify Pharma competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

OrsoBio

Advancing first-in-class therapies to restore energy homeostasis

18 Series A $62.30M

Palo Alto, United States

Biopharma Biotechnology +1

Alaunos Therapeutics

Attacking solid tumors with TCRs

10 Post Ipo Equity $293.39M

Houston, United States

Biotechnology Health and Wellness +1

Azkka

A pharmaceutical company that believes in the Power of Virtue.

Ahmedabad, India

Manufacturing Pharmaceutical

SyneuRx International (Taiwan) Corp.

Developing new classes of drugs for COVID-19 and multiple major central nervous system dis...

12 Post Ipo Equity

Taiwan

Biopharma Pharmaceutical

Rapport Therapeutics

Precision medicines to match the complexity of the human brain.

102 IPO $654.00M

United States

Biotechnology Health Care +1

Response Pharmaceuticals

A Clinical Stage (Phase 2) biopharmaceutical company developing treatments for weight mana...

9 Unknown $11.90M

Biopharma Biotechnology +1

LifestyleRx

Virtual Care for Type 2 Diabetes Reversal

43 Pre Seed $500.00K

Health Care Health and Wellness

Prevail Therapeutics

Wholly owned subsidiary of Eli Lilly and Company

17 Acquired $1.29B

New York, United States

Biotechnology

About Rectify Pharma

Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function for serious diseases.

Services

Development of small molecule therapies, PFM product platform, Orphan disease therapeutics, Drug pipeline development

Target Customers

Healthcare providers, Patients with rare diseases, Medical researchers, Pharmaceutical companies

Taxonomy

Positive Functional Modulators, Small Molecule Therapeutics, Membrane Protein Function, Genetic Diseases, Rare Diseases, Cardio-Renal-Metabolic Diseases, Neurodegenerative Diseases, ABC Transporter Restoration, Precision Therapies, Drug Discovery Platform, Liver Diseases, Series A Funding, Atlas Venture, Omega Funds, Disease-Modifying Therapies

Business Model

B2B, B2D

Revenue Model

Licensing, Product Sales, Performance Based

Frequently Asked Questions

Top alternatives to Rectify Pharma include Mineralys Therapeutics, Inc., MBX Biosciences, Inc., Kallyope, Primus Remedies Pvt Ltd, OrsoBio. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Rectify Pharma based on industry overlap, target customers, and business model.

Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function for serious diseases.

Don't just read about them. Follow them.

BounceWatch watches Rectify Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Rectify Pharma Profile Mineralys Therapeutics, Inc. Alternatives MBX Biosciences, Inc. Alternatives Kallyope Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Rectify Pharma on 28 Jan 2026. The 12 companies listed here were last checked between 28 Nov 2025 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.